There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.

Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in shortage.

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.

Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in shortage.

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.

Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in shortage.

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.